The medicines & conditions can be a bit tricky to say😁… but the simple fact is that the NHS is securing innovative treatments for frontline staff to offer first class care to people across the country. I was delighted to share a few stories at the NHS Board meeting last week

My review of UK commercial clinical trials is published today: https://t.co/i1oUlgRb1K. I'm incredibly grateful to the doctors, nurses, researchers, companies, public servants, charities and patients who contributed.

I'm delighted that pembrolizumab with chemotherapy will be available to women with triple negative breast cancer following another NHS deal. This will benefit up to 1,600 patients each year – like NHS nurse, Lauren who is now almost five years cancer free.

Today, @NHSEngland in partnership with @NICEComms, launch the Innovative Medicines Fund - the Fund will continue NHS momentum as an adopter of medical innovation through agreements that also safeguard value for taxpayers.

Hundreds of people with the most common form of an aggressive lung cancer could survive twice as long, thanks to a drug now available on the NHS. The drug, durvalumab, can double the overall time someone can survive from two and a half to five years. 👉 https://t.co/kYoIwSYjk8

With partners @NICEComms and @DHSCgovuk we’ve taken a big step with our #AMR pilot where the UK is really ‘punching above its weight’ to provide a model for health systems Worldwide.

A revolutionary tumour-stopping drug for lung cancer will be made available to anyone who is eligible, thanks to a new deal announced today. Read how hundreds more patients will now be able to receive this first-of-its-kind treatment. ➡️ https://t.co/BH1X5foNF2

I am pleased that dostarlimab will be available from today via the Cancer Drugs Fund. This is another example of where the CDF will fast-track the most clinically promising treatments to patients whilst further data is collected, which is great news for patients and clinicians

Great news for NHS patients - thanks to the @NHSEngland, @_RocheUK, @NICEComms and @MHRAgovuk working together, the promising lung cancer drug, atezolizumab can be fast-tracked to people with #NSCLC following its licensing through #ProjectOrbis

An important call to arms on AMR. Read more about what NHS England and partners are doing to show leadership in this area https://t.co/BApwjyaz72 #TogetherForAntibiotics

Delighted to announce @NHSEngland has agreed a deal with @Teva_UK to secure a generic version of the drug sapropterin for #PKU patients of all ages in England. After an active 12 months, this latest deal paves the way for 100s of people to benefit from treatment in the New Year

Our NHS commercial medicines deals put innovative treatments into the hands of amazing front-line staff like Dr Elizabeth Wraige. It’s great to hear how this third NHS agreement for new SMA drugs in less than three years is enabling such leaps in patient care & treatment

Excellent news that patients with sickle cell disease will be able to access the first new drug in over 20 years, crizanlizumab. More from @AmandaPritchard here:

Fantastic achievement from the Commercial Medicines Unit who have won the 'Procurement Team of the Year Award’ at the @GOAwardsNews. This award reflects the hard work undertaken to ensure patients with Haemophilia A can access treatments whilst safeguarding the NHS budget

The NHS has today begun the world's largest trial of a new blood test that detects more than 50 types of cancer before symptoms appear. By finding cancer early, we have the best chance of treating it and giving people the best possible chance of survival.

This is one of the most exciting breakthroughs in lung cancer in 20 years. Sotorasib is a precision treatment – now approved in England, but it's a milestone 40 years in the making, with research by @CR_UK and many others. https://t.co/bBEtMyCtS1

Primary care networks incentivised to switch patients to more environmentally friendly inhalers #PJgreenpharmacy https://t.co/bvAPDO1Fly

Delighted that the NHS will now be able to offer patients #inclisiran, a treatment to lower cholesterol, due to our NHS-first 'population health' deal with @Novartis which makes the drug available to a large-scale patient group at a price fair to taxpayers

'My Kaftrio journey has been incredible not just for me, but to start a family as well.' Laura is one of thousands of people with cystic fibrosis in England who has benefited from a life-changing drug — one year on since it was made available on the NHS. https://t.co/Ah0NsCyczg

It's fantastic to see how Kaftrio is helping cystic fibrosis patients, and giving hope, one year after the drug was available following @NHSEngland's deal. Let's hope more people around the world can now benefit from this groundbreaking medicine.